These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12857984)

  • 1. Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.
    Levinson AI; Zheng Y; Gaulton G; Song D; Moore J; Pletcher CH
    Immunol Res; 2003; 27(2-3):399-408. PubMed ID: 12857984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrathymic pathogenesis of myasthenia gravis.
    Levinson AI; Song D; Gaulton G; Zheng Y
    Clin Dev Immunol; 2004; 11(3-4):215-20. PubMed ID: 15559366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the intrathymic pathogenesis of myasthenia gravis.
    Levinson AI
    J Neurol Sci; 2013 Oct; 333(1-2):60-7. PubMed ID: 23332143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new model linking intrathymic acetylcholine receptor expression and the pathogenesis of myasthenia gravis.
    Levinson AI; Zheng Y; Gaulton G; Moore J; Pletcher CH; Song D; Wheatley LM
    Ann N Y Acad Sci; 2003 Sep; 998():257-65. PubMed ID: 14592882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology of myasthenia gravis: innate immunity signature in pathological thymus.
    Cavalcante P; Cufi P; Mantegazza R; Berrih-Aknin S; Bernasconi P; Le Panse R
    Autoimmun Rev; 2013 Jul; 12(9):863-74. PubMed ID: 23535157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The auto-antigen repertoire in myasthenia gravis.
    Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
    Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ; Lo YL
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus, thymoma and myasthenia gravis.
    Fujii Y
    Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thymus and myasthenia gravis.
    Ragheb S; Lisak RP
    Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of myasthenic immunoglobulins on neuromuscular transmission and thymus histology in mice.
    Dalkara T; Onur R; Ruacan SA; Topaktaş S
    Neurology; 1983 Oct; 33(10):1356-9. PubMed ID: 6310440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.
    Koneczny I; Herbst R
    Cells; 2019 Jul; 8(7):. PubMed ID: 31269763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.
    Marx A; Pfister F; Schalke B; Saruhan-Direskeneli G; Melms A; Ströbel P
    Autoimmun Rev; 2013 Jul; 12(9):875-84. PubMed ID: 23535159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis: acetylcholine receptor antibodies and beyond.
    Burde RM
    J Clin Neuroophthalmol; 1981 Mar; 1(1):63-6. PubMed ID: 6213647
    [No Abstract]   [Full Text] [Related]  

  • 16. Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells.
    Wekerle H; Ketelsen UP; Zurn AD; Fulpius BW
    Eur J Immunol; 1978 Aug; 8(8):579-82. PubMed ID: 699955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An imbalance between regulatory T cells and T helper 17 cells in acetylcholine receptor-positive myasthenia gravis patients.
    Villegas JA; Van Wassenhove J; Le Panse R; Berrih-Aknin S; Dragin N
    Ann N Y Acad Sci; 2018 Feb; 1413(1):154-162. PubMed ID: 29405352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic lymphocytes bear a surface antigen which cross-reacts with acetylcholine receptor.
    Fuchs S; Schmidt-Hopfeld I; Tridente G; Tarrab-Hazdai R
    Nature; 1980 Sep; 287(5778):162-4. PubMed ID: 7001247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].
    Berrih-Aknin S; Le Panse R
    Rev Med Interne; 2014 Jul; 35(7):413-20. PubMed ID: 24156976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.